Godrej Agrovet Ltd

During the Q1 FY27 earnings conference call, Godrej Agrovet Limited reported consolidated sales of INR 2,852 crores, reflecting a year-on-year growth of 10%. Management highlighted strong performance in the Animal Nutrition and Oil Palm segments, with the former achieving a 12.6% revenue increase and the latter a 28.9% rise. However, the Crop Care segment faced challenges due to a delayed monsoon, resulting in a 16.2% revenue decline. The Dairy segment reported an 11.4% revenue growth, driven by value-added products. Management noted that the Bangladesh joint venture returned to a growth trajectory, while Astec LifeSciences reached EBITDA breakeven. The company emphasized its focus on balance sheet efficiency and disciplined capital allocation, with improvements in net working capital. Management expressed optimism about future growth despite current challenges in certain segments.

The document presented both positive growth in some segments and challenges in others.